Pfizer details mRNA flu vaccine data, but revises timelinenews2023-10-31T11:46:21+00:00October 31st, 2023|Endpoints News|
Kite partners with epigenetic editing startup Epic Bio in CAR-T worknews2023-10-31T11:30:33+00:00October 31st, 2023|Endpoints News|
Lilly pays $250M for Beam’s opt-in rights to Verve’s cardio genetic medicinesnews2023-10-31T10:00:00+00:00October 31st, 2023|Endpoints News|
Aqtual raises $16M for liquid biopsy test for rheumatoid arthritisnews2023-10-31T04:01:26+00:00October 31st, 2023|Endpoints News|
Sarepta’s confirmatory Duchenne gene therapy study fails to meet primary endpointnews2023-10-30T20:52:39+00:00October 30th, 2023|Endpoints News|
Biden signs sweeping executive order on AI, with changes coming for FDA and healthcarenews2023-10-30T19:47:46+00:00October 30th, 2023|Endpoints News|
One manufacturer responsible for 26 contaminated eye drop products, FDA warnsnews2023-10-30T19:45:17+00:00October 30th, 2023|Endpoints News|
Pfizer cost cuts: Drugmaker closes sites in New Jersey, North Carolinanews2023-10-30T19:21:28+00:00October 30th, 2023|Endpoints News|
WuXi AppTec slashes 2023 growth revenue forecast in half due to drop in demand for early-stage servicesnews2023-10-30T19:11:13+00:00October 30th, 2023|Endpoints News|
Fertility benefits company Progyny shares how it handles startup valuations when looking for dealsnews2023-10-30T18:47:37+00:00October 30th, 2023|Endpoints News|
